These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8275683)

  • 1. The estimation of population pharmacokinetic parameters using an EM algorithm.
    Aarons L
    Comput Methods Programs Biomed; 1993 Sep; 41(1):9-16. PubMed ID: 8275683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Inductive Linearization for simulation and estimation with an application to the Michaelis-Menten model.
    Sharif S; Hasegawa C; Duffull SB
    J Pharmacokinet Pharmacodyn; 2022 Aug; 49(4):445-453. PubMed ID: 35788853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal fat mass cannot be reliably estimated in typical pharmacokinetic studies.
    Wasmann RE; Svensson EM; Schalkwijk SJ; Brüggemann RJ; Ter Heine R
    Eur J Clin Pharmacol; 2021 May; 77(5):727-733. PubMed ID: 33205282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MM Algorithms For Variance Components Models.
    Zhou H; Hu L; Zhou J; Lange K
    J Comput Graph Stat; 2019; 28(2):350-361. PubMed ID: 31592195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Estimation Algorithm for General Linear Single Particle Tracking Models with Time-Varying Parameters.
    Godoy BI; Vickers NA; Andersson SB
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33567600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing heterogeneous populations in latent variable settings through robust estimation.
    Nieser KJ; Cochran AL
    Psychol Methods; 2023 Feb; 28(1):39-60. PubMed ID: 34694831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Expectation Maximization Algorithm for Estimation of Linear Systems with Colored Noise.
    Anil Meera A; Wisse M
    Entropy (Basel); 2021 Oct; 23(10):. PubMed ID: 34682030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadratically convergent algorithm for computing real root of non-linear transcendental equations.
    Thota S; Srivastav VK
    BMC Res Notes; 2018 Dec; 11(1):909. PubMed ID: 30572943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a linearization approximation facilitating stochastic model building.
    Svensson EM; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2014 Apr; 41(2):153-8. PubMed ID: 24623084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Hybrid EM for Linear and Nonlinear Mixed Effects Models with Censored Response.
    Vaida F; Fitzgerald AP; Degruttola V
    Comput Stat Data Anal; 2007 Aug; 51(12):5718-5730. PubMed ID: 19578533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history and future of population pharmacokinetic analysis in drug development.
    Teuscher N
    Xenobiotica; 2024 Jul; 54(7):394-400. PubMed ID: 38051030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of model simulation in pharmacological fields and the problems of theoretical reliability.
    Kariya Y; Honma M
    Drug Metab Pharmacokinet; 2024 Jun; 56():100996. PubMed ID: 38797090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials.
    Huang LH; Bai JL; Yu H; Chen F
    J Biomed Res; 2017 Jun; 32(1):23-9. PubMed ID: 28630393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects Models.
    Bjugård Nyberg H; Hooker AC; Bauer RJ; Aoki Y
    AAPS J; 2020 Jul; 22(4):90. PubMed ID: 32617704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patients.
    Ogungbenro K; Vasist L; Maclaren R; Dukes G; Young M; Aarons L
    Pharm Res; 2011 Feb; 28(2):394-404. PubMed ID: 20949310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
    Bauer RJ; Guzy S; Ng C
    AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.
    Pillai GC; Mentré F; Steimer JL
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):161-83. PubMed ID: 16283536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patients.
    Evans L; Aarons L; Coates P
    Pharm Res; 1999 Oct; 16(10):1608-15. PubMed ID: 10554105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes.
    Bressolle F; Audran M; Gareau R; Pham TN; Gomeni R
    J Pharmacokinet Biopharm; 1997 Jun; 25(3):263-75. PubMed ID: 9474529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.
    Jelliffe RW; Schumitzky A; Bayard D; Milman M; Van Guilder M; Wang X; Jiang F; Barbaut X; Maire P
    Clin Pharmacokinet; 1998 Jan; 34(1):57-77. PubMed ID: 9474473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.